Understanding Peptide Purity: HPLC, Mass Spec & CoA Reading

Peptide purity refers to the percentage of the desired peptide in a given sample, with the remainder being impurities — failed sequences, deletion peptides, truncated fragments, oxidised variants, and residual chemicals from the synthesis process.

Why It Matters for Research: - Reproducibility: Impure peptides produce inconsistent results. If a vial labelled "BPC-157" contains only 70% actual BPC-157, the effective dose is 30% lower than calculated. - Safety: Impurities can include toxic synthesis byproducts (TFA, DMF, coupling reagents) that pose health risks. - Interpretation: Research findings cannot be reliably attributed to a peptide's effects if significant impurities are present — the observed effects may be caused by contaminants.

Purity Grades: - >98%: Research/pharmaceutical grade — suitable for in vivo research - 95–98%: Standard research grade — adequate for most applications - 90–95%: Lower grade — acceptable for in vitro screening but not recommended for in vivo use - <90%: Crude — unsuitable for biological research

The difference between 95% and 99% purity might seem trivial, but for a 5mg peptide, this represents 0.05mg vs 0.25mg of impurities — a 5-fold difference in contaminant load.

High-Performance Liquid Chromatography (HPLC) is the primary analytical method for determining peptide purity. It separates the components of a peptide sample based on their chemical properties and quantifies the proportion of each component.

How HPLC Works: 1. The peptide sample is dissolved and injected into a column packed with fine particles (stationary phase) 2. A liquid solvent (mobile phase) carries the sample through the column 3. Different molecules interact differently with the stationary phase — the desired peptide, impurities, and byproducts separate based on their polarity and size 4. A UV detector (typically at 214nm or 220nm wavelength) measures each component as it exits the column 5. The result is a chromatogram — a graph showing peaks for each component

Reading an HPLC Chromatogram: - The main peak represents the target peptide - Smaller peaks represent impurities (failed sequences, truncations, modifications) - Purity is calculated as: (area of main peak / total area of all peaks) × 100 - A purity of 98.5% means the main peptide peak accounts for 98.5% of the total UV-absorbing material

Key Details to Check: - Retention time should be consistent with the known peptide - The main peak should be symmetrical (asymmetric peaks may indicate co-eluting impurities) - Baseline resolution between the main peak and impurity peaks indicates good separation - The method conditions (column type, gradient, flow rate) should be appropriate for the specific peptide

While HPLC measures purity (how much of the sample is the target molecule), mass spectrometry (MS) confirms identity (whether the main peak actually is the target molecule). Both are needed for comprehensive quality assessment.

How Mass Spectrometry Works: 1. The peptide is ionised (given an electrical charge) 2. Charged molecules are separated by their mass-to-charge ratio (m/z) 3. A detector measures the abundance of ions at each m/z value 4. The result is a mass spectrum showing peaks at specific molecular weights

Reading a Mass Spectrum: - The observed mass should match the theoretical mass of the target peptide - Mass accuracy within ±0.1% (or ±1 Da for small peptides) is expected - Common adducts: [M+H]+ (protonated), [M+Na]+ (sodiated), [M+2H]²+ (doubly charged) - Multiple charge states help confirm the identity and molecular weight

Types of Mass Spectrometry Used: - MALDI-TOF: Fast screening method, good for confirming molecular weight - ESI-MS: More detailed analysis, often coupled with HPLC (LC-MS) - HRMS (High-Resolution MS): Provides exact mass measurement for unambiguous identification

Red Flags in Mass Spec Data: - Observed mass differs significantly from theoretical mass - Multiple major peaks suggesting a mixture of peptides - Absence of the expected molecular ion - Evidence of oxidation (+16 Da) or deamidation (+1 Da) modifications

A Certificate of Analysis (CoA) is the document that accompanies a peptide product, summarising the quality control testing results. A proper CoA should include:

Essential Information: - Product name and sequence: The peptide name and full amino acid sequence - Lot/batch number: Unique identifier for traceability - Molecular weight: Theoretical molecular weight of the peptide - Purity by HPLC: Percentage purity with method details - Mass spec data: Observed molecular weight confirming identity - Appearance: Physical description (typically white to off-white lyophilised powder) - Solubility: Recommended reconstitution solvents - Date of analysis: When testing was performed

Red Flags on a CoA: - No batch/lot number (may be a generic template, not actual test results) - Missing HPLC chromatogram (just a number without the supporting graph) - No mass spec data (purity without identity confirmation is incomplete) - Purity listed as exactly 99.0% across multiple products (suspicious uniformity) - Outdated testing methods or missing method details - No company name or accreditation information on the testing laboratory

Third-Party Testing: The most reliable CoAs come from independent third-party laboratories rather than the peptide manufacturer's own lab. Third-party testing eliminates conflicts of interest and provides objective quality verification. Look for labs with ISO 17025 accreditation.

Practical Tip: Compare CoAs between suppliers for the same peptide. If one supplier consistently reports 99%+ purity while others report 95–98%, question whether the claims are realistic. Peptide synthesis is inherently imperfect, and very high purity claims should be supported by detailed analytical data.

Disclaimer: This article is for educational purposes only. It is not medical advice. Always obtain peptides from reputable suppliers who provide comprehensive analytical documentation.